Freedman Financial Associates’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-826
Closed -$9K 420
2022
Q1
$9K Buy
826
+79
+11% +$1.04K 0.01% 371
2021
Q4
$10K Sell
747
-143
-16% -$1.91K 0.01% 341
2021
Q3
$12K Buy
890
+12
+1% +$170 0.01% 337
2021
Q2
$13K Sell
878
-246
-22% -$3.56K 0.01% 325
2021
Q1
$16K Sell
1,124
-265
-19% -$4.32K 0.01% 319
2020
Q4
$26K Buy
+1,389
New +$22.7K 0.02% 264

Other funds holding VTRS

Freedman Financial Associates's VTRS Position: Q2 2022 in Review

Freedman Financial Associates sold out of Viatris (VTRS) in Q2 2022, closing a stake of 826 shares — an estimated $9K sold.

Freedman Financial Associates first reported a position in VTRS in Q4 2020 and held it in 6 quarters. The position peaked at $26K in Q4 2020. 1,010 funds tracked by Wall St. Rank hold VTRS as of Q2 2022.

  • Freedman Financial Associates reported no remaining Viatris position as of Q2 2022 after selling out during the quarter.
  • Freedman Financial Associates sold 826 Viatris shares in Q2 2022, an estimated $9K.
  • Freedman Financial Associates first reported a position in Viatris in Q4 2020 and held it in 6 quarters.
  • Freedman Financial Associates's Viatris position peaked at $26K in Q4 2020.
  • 1,010 funds tracked by Wall St. Rank held Viatris as of Q2 2022.

Based on Freedman Financial Associates's 13F filing for Q2 2022.